[ad_1]
Read More »Irbesartan, a medicine for hypertension, evoking a potential cancer risk
FDA issues alert on irbesartan due to contamination
[ad_1] SciGen Pharmaceuticals has voluntarily recalled certain batches of the angiotensin II receptor blocker (ARB), irbesartan, due to the presence of NOT-Nitrosodiethylamine (NDEA), a probable human carcinogen, has announced the US Food …
Read More »FDA: Irbesartan Under Recall Too in the Midst of Valsartan Saga
[ad_1] ScieGen's angiotensin II receptor blocker (ARB) is a carcinogenic protein that has been detected during the testing, and the FDA warned in a MedWatch Safety Alert. Westminster Pharmaceuticals and Golden State …
Read More »